Inhibition of histone deacetylases

Yi Huang, Patrick G. Shaw, Nancy E. Davidson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Lysine acetylation of histones is one of the major epigenetic regulators of chromatin conformation and gene expression. The dynamic nature of histone acetylation is determined by the counterbalancing activity of histone acetyltransferase and histone deacetylase (HDAC) enzymes. Acetylation of histones is generally associated with open and transcriptionally active chromatin, whereas the activity of HDACs leads to histone deacetylation, condensation of chromatin, and inhibition of transcription. Aberrant silencing of tumor suppressors and other genes has been found in different types of cancer. Abnormal activity of HDACs has been implicated in tumorigenesis and therefore considerable effort has been put into the development of HDAC inhibitors as a means of modifying histone acetylation status and reexpressing aberrantly silenced tumor suppressor genes. This has led to the generation of a number of structurally diverse compounds that can effectively inhibit HDAC activity, thus altering chromatin structure in cancer cells. This unit discusses the methods and recent technological developments with respect to the studies of HDAC inhibition in cancer.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
Pages297-311
Number of pages15
Volume791
DOIs
StatePublished - 2011
Externally publishedYes

Publication series

NameMethods in Molecular Biology
Volume791
ISSN (Print)10643745

Fingerprint

Histone Deacetylases
Histones
Acetylation
Chromatin
Tumor Suppressor Genes
Histone Acetyltransferases
Neoplasms
Histone Deacetylase Inhibitors
Epigenomics
Lysine
Carcinogenesis
Gene Expression
Enzymes

Keywords

  • Chromatin remodeling
  • Epigenetic gene silencing
  • HDAC inhibitors
  • Histone acetyltransferases
  • Histone deacetylases

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Huang, Y., Shaw, P. G., & Davidson, N. E. (2011). Inhibition of histone deacetylases. In Methods in Molecular Biology (Vol. 791, pp. 297-311). (Methods in Molecular Biology; Vol. 791). https://doi.org/10.1007/978-1-61779-316-5_22

Inhibition of histone deacetylases. / Huang, Yi; Shaw, Patrick G.; Davidson, Nancy E.

Methods in Molecular Biology. Vol. 791 2011. p. 297-311 (Methods in Molecular Biology; Vol. 791).

Research output: Chapter in Book/Report/Conference proceedingChapter

Huang, Y, Shaw, PG & Davidson, NE 2011, Inhibition of histone deacetylases. in Methods in Molecular Biology. vol. 791, Methods in Molecular Biology, vol. 791, pp. 297-311. https://doi.org/10.1007/978-1-61779-316-5_22
Huang Y, Shaw PG, Davidson NE. Inhibition of histone deacetylases. In Methods in Molecular Biology. Vol. 791. 2011. p. 297-311. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-61779-316-5_22
Huang, Yi ; Shaw, Patrick G. ; Davidson, Nancy E. / Inhibition of histone deacetylases. Methods in Molecular Biology. Vol. 791 2011. pp. 297-311 (Methods in Molecular Biology).
@inbook{f45b3a456fbe494d8cf5b8d41d4171a1,
title = "Inhibition of histone deacetylases",
abstract = "Lysine acetylation of histones is one of the major epigenetic regulators of chromatin conformation and gene expression. The dynamic nature of histone acetylation is determined by the counterbalancing activity of histone acetyltransferase and histone deacetylase (HDAC) enzymes. Acetylation of histones is generally associated with open and transcriptionally active chromatin, whereas the activity of HDACs leads to histone deacetylation, condensation of chromatin, and inhibition of transcription. Aberrant silencing of tumor suppressors and other genes has been found in different types of cancer. Abnormal activity of HDACs has been implicated in tumorigenesis and therefore considerable effort has been put into the development of HDAC inhibitors as a means of modifying histone acetylation status and reexpressing aberrantly silenced tumor suppressor genes. This has led to the generation of a number of structurally diverse compounds that can effectively inhibit HDAC activity, thus altering chromatin structure in cancer cells. This unit discusses the methods and recent technological developments with respect to the studies of HDAC inhibition in cancer.",
keywords = "Chromatin remodeling, Epigenetic gene silencing, HDAC inhibitors, Histone acetyltransferases, Histone deacetylases",
author = "Yi Huang and Shaw, {Patrick G.} and Davidson, {Nancy E.}",
year = "2011",
doi = "10.1007/978-1-61779-316-5_22",
language = "English (US)",
isbn = "9781617793158",
volume = "791",
series = "Methods in Molecular Biology",
pages = "297--311",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Inhibition of histone deacetylases

AU - Huang, Yi

AU - Shaw, Patrick G.

AU - Davidson, Nancy E.

PY - 2011

Y1 - 2011

N2 - Lysine acetylation of histones is one of the major epigenetic regulators of chromatin conformation and gene expression. The dynamic nature of histone acetylation is determined by the counterbalancing activity of histone acetyltransferase and histone deacetylase (HDAC) enzymes. Acetylation of histones is generally associated with open and transcriptionally active chromatin, whereas the activity of HDACs leads to histone deacetylation, condensation of chromatin, and inhibition of transcription. Aberrant silencing of tumor suppressors and other genes has been found in different types of cancer. Abnormal activity of HDACs has been implicated in tumorigenesis and therefore considerable effort has been put into the development of HDAC inhibitors as a means of modifying histone acetylation status and reexpressing aberrantly silenced tumor suppressor genes. This has led to the generation of a number of structurally diverse compounds that can effectively inhibit HDAC activity, thus altering chromatin structure in cancer cells. This unit discusses the methods and recent technological developments with respect to the studies of HDAC inhibition in cancer.

AB - Lysine acetylation of histones is one of the major epigenetic regulators of chromatin conformation and gene expression. The dynamic nature of histone acetylation is determined by the counterbalancing activity of histone acetyltransferase and histone deacetylase (HDAC) enzymes. Acetylation of histones is generally associated with open and transcriptionally active chromatin, whereas the activity of HDACs leads to histone deacetylation, condensation of chromatin, and inhibition of transcription. Aberrant silencing of tumor suppressors and other genes has been found in different types of cancer. Abnormal activity of HDACs has been implicated in tumorigenesis and therefore considerable effort has been put into the development of HDAC inhibitors as a means of modifying histone acetylation status and reexpressing aberrantly silenced tumor suppressor genes. This has led to the generation of a number of structurally diverse compounds that can effectively inhibit HDAC activity, thus altering chromatin structure in cancer cells. This unit discusses the methods and recent technological developments with respect to the studies of HDAC inhibition in cancer.

KW - Chromatin remodeling

KW - Epigenetic gene silencing

KW - HDAC inhibitors

KW - Histone acetyltransferases

KW - Histone deacetylases

UR - http://www.scopus.com/inward/record.url?scp=80054737699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054737699&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-316-5_22

DO - 10.1007/978-1-61779-316-5_22

M3 - Chapter

C2 - 21913088

AN - SCOPUS:80054737699

SN - 9781617793158

VL - 791

T3 - Methods in Molecular Biology

SP - 297

EP - 311

BT - Methods in Molecular Biology

ER -